Japan News
-
Japan approves self-amplifying mRNA COVID-19 vaccine for protection against JN.1 strain
Japan | News | 0 Comment | 13 Sep, 2024
Global biotechnology leader CSL and self amplifying-mRNA pioneer Arcturus Therapeutics have announced that Japan's Minis...Read more
-
French firm Osivax grants rights to KM Biologics to develop and market influenza vaccine in Japan
Japan | News | 0 Comment | 10 Sep, 2024
Osivax, a FRance-based biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly...Read more
-
Japan | News | By Ankit Kankar | ankit.kankar@mmactiv.com | 0 Comment | 01 Sep, 2024
Antibody Engineering & Therapeutics Asia: Date: October 21 – 23, 2024Location: The Westin Miyako Kyoto Antib...Read more
-
Japan | News | 0 Comment | 06 Sep, 2024
Takara Bio USA, Inc., a wholly owned subsidiary of Japan-based Takara Bio Inc., has announced the launch of the SmartChi...Read more
-
US-based Rigel inks $162.5 M oncology deal with Kissei for Japan, Korea and Taiwan markets
Japan | News | 0 Comment | 05 Sep, 2024
US-based Rigel Pharmaceuticals, Inc., a commercial stage biotechnology company focused on hematologic disorders and canc...Read more
-
Japan's Rigaku Corp develops solution to accelerate biopharmaceutical R&D
Japan | News | 0 Comment | 04 Sep, 2024
Rigaku Corporation, a Rigaku Holdings Group company and global partner for X-ray analysis from Lab to Fab in Japan, has ...Read more
-
Japan | News | 0 Comment | 02 Sep, 2024
The Biomedical Division of PHC Corporation, based in Japan, will present a prototype of its new cell expansion syst...Read more
-
Strategies for Success in Japan’s Biotech Ecosystem
Japan | Opinion | By Stefan Sandström, Founder and CEO, Biosector, Tokyo | 0 Comment | 01 Sep, 2024
Japan’s biotech sector is a landscape rife with opportunity, yet also a complex market that requires a deep unders...Read more
-
Advancing Japan’s Biotech Ecosystem: Current Initiatives and Future Outlook
Japan | Opinion | By Kikuo Yasui, Chief Operating Officer, Director of the Board Heartseed | 0 Comment | 01 Sep, 2024
Japan has a robust drug discovery capability, having developed an interleukin-6 inhibitor, a programmed cell death prote...Read more
-
Boosting Japan’s Biotech Ecosystem
Japan | Opinion | By Andrew Sanden, Co-CEO, Intrinsic Japan K.K. / Intrinsic Innovations | 0 Comment | 01 Sep, 2024
Japan's biotech ecosystem is at a pivotal moment, characterised by both challenges and opportunities. Despite a rich his...Read more
-
Rebooting Japan's biotech growth engine
Japan | Analysis | By Ayesha Siddiqui | 0 Comment | 01 Sep, 2024
On July 30 2024, Japanese Prime Minister Fumio Kishida unveiled a roadmap to establish Japan as a ‘drug discovery ...Read more
-
Kaneka completes construction of medical device plant in Hokkaido, Japan
Japan | News | 0 Comment | 30 Aug, 2024
Kaneka Corporation has opened its Tomatoh Manufacturing Site in the Tomakomai Tobu Area of Hokkaido, Japan for the purpo...Read more
-
Hitachi and Gencurix enter into partnership to expand cancer molecular diagnostics biz in Japan
Japan | News | 0 Comment | 29 Aug, 2024
Japanese firm Hitachi High-Tech Corporation and Korea-based Gencurix, Inc. have entered a strategic partnership in the f...Read more
-
Japanese medtech firm Olympus extends advanced bipolar surgical energy portfolio
Japan | News | 0 Comment | 27 Aug, 2024
Japan-based Olympus Corporation, a global medical technology company, has announced the launch of two new jaw designs in...Read more
-
Hitachi High-Tech launches new tabletop microscopes with enhanced usability
Japan | News | 0 Comment | 24 Aug, 2024
Japan-based Hitachi High-Tech Corporation has announced the global launch of TM4000PlusIII and TM4000III Tabletop Micros...Read more
-
MEDICAL JAPAN 2024 TOKYO Expands Horizons with New Trade Fairs and Comprehensive Healthcare Coverage
Japan | News | 0 Comment | 14 Aug, 2024
Like in the previous edition, MEDICAL JAPAN TOKYO features six sub shows. First off is the HOSPITAL EXPO, which i...Read more
-
Japan | News | 0 Comment | 12 Aug, 2024
Aevice Health, a leading provider of remote monitoring solutions for chronic respiratory disease management, has raised ...Read more
-
Daiichi Sankyo and Merck ink $170 M deal to commercialise cancer drug
Japan | News | 0 Comment | 08 Aug, 2024
Japan-based pharma firm Daiichi Sankyo and global life sciences company Merck, known as MSD outside of the United States...Read more
